- Home
- ZYME vs WERN Comparison
ZYME vs WERN Comparison
Compare ZYME & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZYME | WERN |
|---|---|---|
| Founded | 2003 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ZYME | WERN |
|---|---|---|
| Price | $22.88 | $27.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 14 |
| Target Price | ★ $38.90 | $31.21 |
| AVG Volume (30 Days) | 630.3K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $105,965,000.00 | ★ $2,974,396,000.00 |
| Revenue This Year | $162.82 | $21.37 |
| Revenue Next Year | N/A | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $9.03 | $23.02 |
| 52 Week High | $28.49 | $38.45 |
Technical Indicators
Market Signals| Indicator | ZYME | WERN |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 29.36 |
| Support Level | $22.23 | $26.64 |
| Resistance Level | $23.66 | $29.62 |
| Average True Range (ATR) | 1.42 | 1.37 |
| MACD | -0.05 | -0.73 |
| Stochastic Oscillator | 9.06 | 11.84 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.